Rappta Therapeutics
Helsinki
About Rappta Therapeutics
Rappta Therapeutics is a lead-optimization stage biopharmaceutical company. We are working on a first-in-class series of anti-cancer molecules that reactivate a key tumor suppressor, protein phosphatase 2A (PP2A).
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $10.6M
- Funding stage: Early Stage Venture
- Last round: Series A (Oct 2020)
- Website: rappta-therapeutics.com
- Phone: [email protected]
Industries & Categories
Biopharma, Biotechnology, Life Science
Social Profiles
Canonical: https://fsome.com/organization/rappta-therapeutics-99694 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.